Stryker - SYK Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $259.33
Forecasted Upside: 3.92%
Number of Analysts: 18
Breakdown:
0 Sell Ratings
7 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$249.54 As of 01/30/2023 01:00 AM ET

▼ -4.63 (-1.82%)

1 month | 3 months | 12 months

Get New Stryker Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for SYK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SYK

^$259.33

▲ +3.92% Upside Potential

This price target is based on 18 analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $259.33, with a high forecast of $295.00 and a low forecast of $205.00. The average price target represents a 3.92% upside from the last price of $249.54.

Current Consensus is Buy

The current consensus among 18 polled investment analysts is to buy stock in Stryker. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
13 buy ratings
8 hold ratings
0 sell ratings

Ratings as of

8/9/2021

0 strong buy ratings
13 buy ratings
7 hold ratings
0 sell ratings

Ratings as of

11/7/2021

0 strong buy ratings
15 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

2/5/2022

0 strong buy ratings
13 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

5/6/2022

0 strong buy ratings
10 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

8/4/2022

0 strong buy ratings
13 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

11/2/2022

0 strong buy ratings
12 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

1/1/2023

0 strong buy ratings
11 buy ratings
7 hold ratings
0 sell ratings

Ratings as of

1/31/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
1/25/2023	KeyCorp	Initiated Coverage	Sector Weight ➝ Sector Weight		Low
1/9/2023	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$240.00 ➝ $284.00	Low
1/6/2023	Morgan Stanley	Boost Target	Equal Weight	$220.00 ➝ $260.00	Low
1/4/2023	Barclays	Boost Target		$257.00 ➝ $265.00	Low
1/3/2023	Evercore ISI	Boost Target		$265.00	Low
12/21/2022	BTIG Research	Boost Target		$232.00 ➝ $268.00	Low
12/20/2022	Truist Financial	Boost Target	Hold	$230.00 ➝ $252.00	Low
12/14/2022	Cowen	Boost Target		$233.00 ➝ $283.00	Low
12/14/2022	Cowen	Boost Target		$233.00 ➝ $283.00	Low
12/12/2022	Wells Fargo & Company	Boost Target	Overweight	$248.00 ➝ $281.00	Low
12/12/2022	Citigroup	Boost Target		$249.00 ➝ $282.00	Low
12/1/2022	Barclays	Boost Target	Overweight	$239.00 ➝ $257.00	Low
11/4/2022	Truist Financial	Boost Target		$230.00	Low
11/1/2022	Royal Bank of Canada	Lower Target	Sector Perform	$255.00 ➝ $240.00	Low
11/1/2022	Canaccord Genuity Group	Downgrade	Buy ➝ Hold	$225.00 ➝ $220.00	Low
11/1/2022	Wells Fargo & Company	Boost Target	Overweight	$237.00 ➝ $248.00	Low
11/1/2022	Canaccord Genuity Group	Downgrade	Buy ➝ Hold	$225.00 ➝ $220.00	Low
10/17/2022	Barclays	Initiated Coverage	Overweight	$239.00	Low
10/17/2022	BTIG Research	Lower Target	Buy	$238.00 ➝ $232.00	Low
10/12/2022	Jefferies Financial Group	Initiated Coverage	Buy	$270.00	Low
10/10/2022	Piper Sandler	Lower Target		$260.00 ➝ $250.00	N/A
10/5/2022	Citigroup	Lower Target		$255.00 ➝ $246.00	Low
9/14/2022	Piper Sandler	Boost Target	Overweight	$250.00 ➝ $260.00	Low
9/6/2022	BTIG Research	Lower Target	Buy	$244.00 ➝ $238.00	Low
7/28/2022	Edward Jones	Upgrade	Hold ➝ Buy		Low
7/27/2022	Truist Financial	Boost Target	Outperform	$220.00	Low
7/27/2022	Robert W. Baird	Lower Target	Outperform ➝ Outperform	$297.00 ➝ $240.00	Low
7/27/2022	Piper Sandler	Lower Target	Overweight	$290.00 ➝ $250.00	Low
7/22/2022	Truist Financial	Lower Target		$213.00	Low
7/22/2022	Cowen	Lower Target	Outperform	$305.00 ➝ $233.00	Low
7/21/2022	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$285.00 ➝ $205.00	Low
7/18/2022	BTIG Research	Lower Target	Buy	$278.00 ➝ $244.00	Low
7/18/2022	Stifel Nicolaus	Lower Target		$285.00 ➝ $245.00	Low
7/15/2022	Morgan Stanley	Lower Target	Equal Weight	$270.00 ➝ $220.00	Low
7/11/2022	Bank of America	Downgrade	Buy ➝ Neutral		N/A
5/17/2022	Citigroup	Lower Target		$310.00 ➝ $280.00	N/A
5/2/2022	Truist Financial	Lower Target		$296.00 ➝ $280.00	Low
4/29/2022	Piper Sandler	Lower Target		$315.00 ➝ $290.00	High
4/18/2022	BTIG Research	Boost Target		$273.00 ➝ $278.00	Low
4/12/2022	Truist Financial	Initiated Coverage	Hold	$296.00	Low
3/16/2022	Sanford C. Bernstein	Upgrade	Market Perform ➝ Outperform	$288.00 ➝ $295.00	Medium
3/15/2022	Evercore ISI	Reiterated Rating	Outperform	$284.00	High
3/1/2022	Bank of America	Initiated Coverage	Buy ➝ Buy		High
1/31/2022	Morgan Stanley	Lower Target	Equal Weight	$305.00 ➝ $275.00	Low
1/28/2022	SVB Leerink	Lower Target	Outperform	$300.00 ➝ $285.00	High
1/28/2022	BTIG Research	Lower Target	Buy	$280.00 ➝ $273.00	High
1/28/2022	Citigroup	Lower Target		$300.00 ➝ $290.00	High
1/7/2022	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$305.00	High
1/4/2022	Piper Sandler	Upgrade	Neutral ➝ Overweight	$250.00 ➝ $315.00	High
12/9/2021	Royal Bank of Canada	Initiated Coverage	Sector Perform	$278.00	Low
12/6/2021	Loop Capital	Initiated Coverage	Buy	$305.00	High
11/19/2021	Morgan Stanley	Boost Target	Overweight	$295.00 ➝ $305.00	High
10/29/2021	Robert W. Baird	Reiterated Rating	Buy	$301.00	Medium
10/29/2021	Piper Sandler	Boost Target	Neutral	$250.00 ➝ $255.00	High
10/22/2021	SVB Leerink	Reiterated Rating	Outperform		Medium
9/14/2021	Raymond James	Initiated Coverage	Market Perform		Medium
7/29/2021	Argus	Boost Target	Buy	$280.00 ➝ $320.00	Low
7/28/2021	Truist Financial	Boost Target	Hold	$250.00 ➝ $275.00	Medium
7/28/2021	Morgan Stanley	Boost Target	Overweight	$280.00 ➝ $300.00	Low
7/28/2021	SVB Leerink	Boost Target	Outperform	$290.00 ➝ $300.00	Low
7/28/2021	Credit Suisse Group	Boost Target	Outperform	$291.00 ➝ $311.00	Low
7/28/2021	Oppenheimer	Boost Target	Market Perform	$273.00 ➝ $288.00	Low
7/28/2021	Northland Securities	Upgrade	Market Perform ➝ Outperform	$248.00 ➝ $310.00	Low
7/28/2021	Needham & Company LLC	Reiterated Rating	Hold		Medium
7/28/2021	Robert W. Baird	Boost Target	Outperform	$292.00 ➝ $305.00	Medium
7/28/2021	Citigroup	Boost Target	Buy	$303.00 ➝ $310.00	Medium
7/28/2021	Piper Sandler	Boost Target	Neutral	$250.00 ➝ $255.00	Medium
7/20/2021	SVB Leerink	Reiterated Rating	Outperform		Medium
6/28/2021	Credit Suisse Group	Reiterated Rating	Buy	$291.00	Low
6/1/2021	Evercore ISI	Upgrade	In-Line ➝ Outperform	$260.00 ➝ $285.00	High
5/24/2021	Barclays	Initiated Coverage	Underweight	$280.00	Low
4/28/2021	Oppenheimer	Boost Target		$240.00 ➝ $273.00	High
4/28/2021	Truist Financial	Boost Target		$245.00 ➝ $255.00	High
4/28/2021	Citigroup	Boost Target		$264.00 ➝ $303.00	High
4/28/2021	Morgan Stanley	Boost Target	Overweight	$265.00 ➝ $280.00	Medium
4/28/2021	Wells Fargo & Company	Boost Target	Overweight	$265.00 ➝ $300.00	High
4/28/2021	Raymond James	Boost Target	Outperform	$255.00 ➝ $290.00	Medium
4/28/2021	Cowen	Boost Target	Outperform	$255.00 ➝ $279.00	High
4/28/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$251.00 ➝ $285.00	High
4/28/2021	Robert W. Baird	Boost Target	Outperform	$265.00 ➝ $292.00	High
2/24/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$245.00 ➝ $265.00	Low
1/28/2021	Credit Suisse Group	Lower Target	Outperform ➝ Outperform	$278.00 ➝ $273.00	Low
1/28/2021	Morgan Stanley	Lower Target	Overweight	$272.00 ➝ $265.00	High
1/28/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$228.00 ➝ $251.00	Low
1/28/2021	Raymond James	Boost Target	Outperform	$240.00 ➝ $255.00	Low
1/28/2021	Needham & Company LLC	Reiterated Rating	Hold		Low
1/6/2021	Truist Financial	Boost Target		$210.00 ➝ $245.00	N/A
1/6/2021	Credit Suisse Group	Boost Target	Outperform	$253.00 ➝ $278.00	N/A
1/4/2021	Guggenheim	Initiated Coverage	Neutral		N/A
12/31/2020	BTIG Research	Boost Target	Buy	$234.00 ➝ $252.00	N/A
12/15/2020	Morgan Stanley	Boost Target	Overweight	$225.00 ➝ $272.00	Low
11/12/2020	Robert W. Baird	Boost Target	Outperform	$243.00 ➝ $258.00	Low
10/30/2020	Smith Barney Citigroup	Boost Target		$232.00 ➝ $240.00	High
10/30/2020	SVB Leerink	Boost Target	Outperform	$225.00 ➝ $235.00	High
10/30/2020	Credit Suisse Group	Boost Target	Outperform	$243.00 ➝ $253.00	High
10/12/2020	Raymond James	Boost Target	Outperform	$220.00 ➝ $240.00	Medium
10/6/2020	Northland Securities	Initiated Coverage	Market Perform	$225.00	Medium
9/28/2020	Wells Fargo & Company	Boost Target	Overweight	$222.00 ➝ $232.00	Medium
9/11/2020	Wolfe Research	Initiated Coverage	Market Perform	$230.00	Low
7/31/2020	UBS Group	Boost Target	Neutral	$202.00 ➝ $215.00	High
7/31/2020	Morgan Stanley	Boost Target	Overweight	$215.00 ➝ $225.00	Low
7/31/2020	SVB Leerink	Boost Target	Outperform	$215.00 ➝ $225.00	Medium
7/31/2020	Credit Suisse Group	Boost Target	Outperform	$237.00 ➝ $243.00	High
7/31/2020	Needham & Company LLC	Reiterated Rating	Hold		Medium
7/31/2020	Oppenheimer	Reiterated Rating	Hold	$215.00	Medium
7/31/2020	Citigroup	Boost Target	Buy	$227.00 ➝ $232.00	Medium
7/15/2020	SVB Leerink	Reiterated Rating	Outperform		Low
5/11/2020	Argus	Lower Target	Buy	$240.00 ➝ $230.00	Low
5/1/2020	Citigroup	Boost Target	Buy	$200.00 ➝ $215.00	Medium
5/1/2020	Cfra	Lower Target	Strong-Buy	$234.00 ➝ $231.00	Low
5/1/2020	Wells Fargo & Company	Boost Target	Overweight	$201.00 ➝ $205.00	Medium
5/1/2020	Morgan Stanley	Boost Target	Overweight	$210.00 ➝ $215.00	High
5/1/2020	Stifel Nicolaus	Boost Target	Buy	$145.00 ➝ $205.00	High
5/1/2020	UBS Group	Lower Target	Neutral	$230.00 ➝ $202.00	High
5/1/2020	Oppenheimer	Reiterated Rating	Hold	$200.00	Medium
5/1/2020	Credit Suisse Group	Boost Target	Outperform	$229.00 ➝ $237.00	Medium
5/1/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$243.00 ➝ $228.00	High
4/22/2020	Cowen	Lower Target	Outperform	$240.00 ➝ $220.00	Low
4/15/2020	JPMorgan Chase & Co.	Lower Target	Overweight	$240.00 ➝ $210.00	Medium
4/13/2020	Raymond James	Lower Target	Outperform	$240.00 ➝ $205.00	High
4/13/2020	Barclays	Downgrade	Equal Weight ➝ Underweight	$155.00	High
4/1/2020	Wells Fargo & Company	Lower Target	Overweight	$243.00 ➝ $201.00	Medium
4/1/2020	The Goldman Sachs Group	Downgrade	Buy ➝ Sell	$248.00 ➝ $150.00	High
3/27/2020	Morgan Stanley	Lower Target	Overweight	$250.00 ➝ $210.00	Low
3/27/2020	Citigroup	Lower Target	Buy	$235.00 ➝ $200.00	Medium
3/25/2020	Credit Suisse Group	Lower Target	Outperform	$247.00 ➝ $162.00	Low
3/24/2020	Stifel Nicolaus	Lower Target	Buy	$250.00 ➝ $145.00	High
3/6/2020	Credit Suisse Group	Lower Target	Outperform	$255.00 ➝ $247.00	Low
3/4/2020	Citigroup	Initiated Coverage	Buy	$235.00	High
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$248.00	Low
1/30/2020	BTIG Research	Reiterated Rating	Buy		Medium
1/29/2020	Cantor Fitzgerald	Reiterated Rating	Neutral		Medium
1/29/2020	Stifel Nicolaus	Boost Target	Buy	$245.00 ➝ $250.00	Low
1/29/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$239.00 ➝ $243.00	Low
1/29/2020	Robert W. Baird	Boost Target	Outperform	$242.00 ➝ $248.00	High
1/29/2020	Morgan Stanley	Boost Target	Overweight	$242.00 ➝ $250.00	High
1/7/2020	SunTrust Banks	Initiated Coverage	Hold	$217.00	Low
1/7/2020	Piper Sandler	Downgrade	Overweight ➝ Neutral	$210.00	Low
1/7/2020	Piper Jaffray Companies	Downgrade	Overweight ➝ Neutral	$210.00	Medium
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$179.00	Low
1/2/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform		Low
12/30/2019	BTIG Research	Boost Target	Buy	$228.00 ➝ $236.00	Low
12/17/2019	Morgan Stanley	Boost Target	Overweight	$230.00 ➝ $242.00	High
11/5/2019	Barclays	Downgrade	Overweight ➝ Equal Weight	$226.00 ➝ $207.00	High
10/30/2019	Robert W. Baird	Boost Target	Outperform	$239.00 ➝ $242.00	Medium
10/30/2019	Bank of America	Boost Target	Buy	$220.00 ➝ $245.00	High
9/5/2019	BTIG Research	Set Target	Buy	$228.00	Medium
9/4/2019	Piper Jaffray Companies	Reiterated Rating	Buy		Low
7/29/2019	BTIG Research	Reiterated Rating	Buy	$228.00	Low
7/26/2019	Raymond James	Set Target	Buy	$240.00	Low
7/26/2019	Royal Bank of Canada	Set Target	Buy	$220.00	Low
7/26/2019	BMO Capital Markets	Set Target	Hold	$216.00	Low
7/26/2019	Barclays	Set Target	Buy	$226.00	N/A
7/26/2019	Robert W. Baird	Boost Target	Outperform	$206.00 ➝ $239.00	Low
7/26/2019	Credit Suisse Group	Boost Target	Outperform	$232.00 ➝ $237.00	Low
7/26/2019	Cantor Fitzgerald	Boost Target	Neutral	$190.00 ➝ $230.00	High
7/26/2019	Piper Jaffray Companies	Boost Target	Overweight	$205.00 ➝ $240.00	High
7/16/2019	Morgan Stanley	Boost Target	Overweight	$218.00 ➝ $230.00	Low
7/15/2019	BTIG Research	Boost Target	Buy ➝ Positive	$219.00	Medium
7/11/2019	Credit Suisse Group	Boost Target	Outperform	$200.00 ➝ $232.00	Low
7/10/2019	SVB Leerink	Reiterated Rating	Outperform		Low
7/2/2019	Wells Fargo & Company	Boost Target	Outperform	$219.00 ➝ $228.00	Low
4/24/2019	Oppenheimer	Boost Target	Outperform	$183.00 ➝ $192.00	Low
4/24/2019	Robert W. Baird	Boost Target	Outperform ➝ Outperform	$201.00 ➝ $206.00	Low
4/24/2019	Deutsche Bank Aktiengesellschaft	Boost Target	Buy ➝ Buy	$181.00 ➝ $208.00	Low
4/24/2019	Cantor Fitzgerald	Boost Target	Neutral ➝ Neutral	$175.00 ➝ $190.00	Low
4/15/2019	Barclays	Boost Target	Overweight ➝ Overweight	$203.00 ➝ $211.00	Low
4/1/2019	Wells Fargo & Company	Boost Target	Outperform	$214.00 ➝ $219.00	Low
3/19/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$200.00 ➝ $215.00	Medium
3/18/2019	BTIG Research	Boost Target	Buy	$211.00	Low
3/11/2019	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$184.00 ➝ $204.00	Medium
3/8/2019	Barclays	Set Target	Buy	$203.00	Low
3/4/2019	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$200.00 ➝ $218.00	Low
3/1/2019	Piper Jaffray Companies	Reiterated Rating	Overweight	$205.00	Medium
2/4/2019	SunTrust Banks	Boost Target	Buy ➝ Positive	$205.00	Low
1/31/2019	Credit Suisse Group	Upgrade	Outperform		Medium
1/18/2019	Cantor Fitzgerald	Reiterated Rating	Neutral		Medium
1/2/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy ➝ Buy	$179.00	Medium
1/2/2019	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$212.00 ➝ $197.00	Low
1/2/2019	Citigroup	Lower Target	Neutral ➝ Neutral	$174.00 ➝ $169.00	Low
1/2/2019	Evercore ISI	Upgrade	In-Line ➝ Outperform	$156.75	Medium
12/17/2018	Credit Suisse Group	Initiated Coverage	Outperform	$195.00	Low
11/27/2018	UBS Group	Initiated Coverage	Neutral	$180.00 ➝ $180.00	High
11/15/2018	Citigroup	Boost Target	Neutral ➝ Neutral	$173.00 ➝ $174.00	Medium
11/9/2018	Oppenheimer	Set Target	Hold	$170.00	N/A
11/9/2018	Cowen	Set Target	Buy	$195.00	Low
11/9/2018	Needham & Company LLC	Reiterated Rating	Hold		Low
10/26/2018	Oppenheimer	Set Target	Hold	$170.00	Medium
10/15/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$198.00	High
9/13/2018	JPMorgan Chase & Co.	Boost Target	Overweight	$200.00	Medium
9/12/2018	BTIG Research	Reiterated Rating	Buy	$187.00	Low
9/11/2018	Needham & Company LLC	Reiterated Rating	Hold		Low
8/16/2018	BTIG Research	Initiated Coverage	Buy	$187.00	Medium
7/25/2018	Oppenheimer	Set Target	Hold	$170.00	Medium
7/25/2018	Robert W. Baird	Boost Target	Outperform ➝ Outperform	$187.00 ➝ $192.00	Medium
7/25/2018	Citigroup	Boost Target	Neutral ➝ Neutral	$171.00 ➝ $173.00	High
7/25/2018	Cantor Fitzgerald	Boost Target	Neutral ➝ Neutral	$170.00 ➝ $175.00	High
7/25/2018	Royal Bank of Canada	Reiterated Rating	Buy	$184.00	High
7/25/2018	Needham & Company LLC	Reiterated Rating	Hold		High
7/12/2018	BMO Capital Markets	Reiterated Rating	Hold	$174.00	Low
6/27/2018	Sanford C. Bernstein	Initiated Coverage	Market Perform	$177.00	Medium
6/13/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$170.00	Low
5/1/2018	Citigroup	Boost Target	Neutral ➝ Neutral	$166.00 ➝ $171.00	Low
4/27/2018	BMO Capital Markets	Boost Target	Market Perform	$170.00	Medium
4/27/2018	Stifel Nicolaus	Boost Target	Buy ➝ Buy	$183.00 ➝ $187.00	Low
4/27/2018	Cantor Fitzgerald	Reiterated Rating	Hold ➝ Neutral		High
4/2/2018	Evercore ISI	Initiated Coverage	In-Line	$165.00	Medium
3/15/2018	Raymond James	Initiated Coverage	Outperform	$183.00	Low
2/27/2018	Citigroup	Upgrade	Sell ➝ Neutral	$165.77 ➝ $166.00	Medium
2/26/2018	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$179.00 ➝ $186.00	High
2/1/2018	Oppenheimer	Reiterated Rating	Hold	$165.00	Low
2/1/2018	Citigroup	Reiterated Rating	Market Perform	$156.00 ➝ $165.00	Low
1/31/2018	Guggenheim	Reiterated Rating	Buy		Low
1/31/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$170.00	Low
1/31/2018	Needham & Company LLC	Reiterated Rating	Hold		Medium
1/31/2018	SVB Leerink	Boost Target	Outperform ➝ Outperform	$177.00 ➝ $184.00	Low

(Data available from 1/31/2018 forward)

News Sentiment Rating

0.74 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

5 very positive mentions
13 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

7/5/2022

3 very positive mentions
23 positive mentions
8 negative mentions
2 very negative mentions

Mentions as of

8/4/2022

2 very positive mentions
22 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

9/3/2022

3 very positive mentions
26 positive mentions
1 negative mentions
2 very negative mentions

Mentions as of

10/3/2022

9 very positive mentions
19 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

11/2/2022

5 very positive mentions
10 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

12/2/2022

12 very positive mentions
8 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

1/1/2023

14 very positive mentions
8 positive mentions
1 negative mentions
2 very negative mentions

Mentions as of

1/31/2023

Current Sentiment

Recent Stories by Sentiment

Stryker Corp. operates as a medical technology company. It operates through the following segments: Orthopaedics & Spine and MedSurg & Neurotechnology. The Orthopaedics & Spine segment provides implants for use in total joint replacements, such as hip, knee, and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that are used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, patient & caregiver safety technologies, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques, products for brain and open skull based surgical procedures, orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products, minimally invasive products fo

Today's Range

Now: $249.54

$249.27

$254.16

50 Day Range

MA: $245.76

$224.65

$263.81

52 Week Range

Now: $249.54

$188.84

$279.28

Volume

1,209,465 shs

Average Volume

1,341,709 shs

Market Capitalization

$94.43 billion

P/E Ratio

38.81

Dividend Yield

1.19%

Beta

0.94

Frequently Asked Questions

What sell-side analysts currently cover shares of Stryker?: The following sell-side analysts have issued reports on Stryker in the last year: Bank of America Co., Barclays PLC, BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., Cowen Inc, Cowen Inc., Deutsche Bank Aktiengesellschaft, Edward Jones, Evercore ISI, Jefferies Financial Group Inc., KeyCorp, Morgan Stanley, Piper Sandler, Robert W. Baird, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, TheStreet, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for SYK.
What is the current price target for Stryker?: 18 Wall Street analysts have set twelve-month price targets for Stryker in the last year. Their average twelve-month price target is $259.33, suggesting a possible upside of 3.9%. Sanford C. Bernstein has the highest price target set, predicting SYK will reach $295.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $205.00 for Stryker in the next year.
View the latest price targets for SYK.
What is the current consensus analyst rating for Stryker?: Stryker currently has 7 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SYK will outperform the market and that investors should add to their positions of Stryker.
View the latest ratings for SYK.
What other companies compete with Stryker?: Other companies that are similar to Stryker include Becton, Dickinson and, Boston Scientific, DexCom, ResMed and Intuitive Surgical. Learn More about companies similar to Stryker.
How do I contact Stryker's investor relations team?: Stryker's physical mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company's listed phone number is (269) 385-2600 and its investor relations email address is [email protected] The official website for Stryker is www.strykercorp.com. Learn More about contacing Stryker investor relations.

Stryker - SYK Stock Price Target and Predictions

Analyst Price Target for SYK

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.74 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Stryker?

What is the current price target for Stryker?

What is the current consensus analyst rating for Stryker?

What other companies compete with Stryker?

How do I contact Stryker's investor relations team?